Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
42 studies found for:    Open Studies | "Cerebellar Diseases"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Emotional Communication Disorders in Cerebellar Disease
Condition: Cerebellar Diseases
Interventions: Behavioral: Testing of emotional communication ability;   Procedure: magnetic resonance imaging (MRI) of the brain
2 Recruiting Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait in Patients With Cerebellar Ataxia Gene
Condition: Cerebellar Ataxia
Interventions: Other: Longitudinal Monitoring of Energy Expenditure, Dynamic Stability and Fatigue During Gait;   Other: walking track GAITRite,manual dynamometer, and treadmill
3 Not yet recruiting An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Condition: Spinocerebellar Degeneration
Interventions: Drug: KPS-0373;   Drug: Placebo
4 Recruiting Augmenting Balance in Individuals With Cerebellar Ataxias
Condition: Cerebellar Ataxia
Intervention: Behavioral: Sensory Augmentation
5 Recruiting Slowing Down Disease Progression in Premanifest SCA: a Piloting Interventional Exergame Trial
Condition: Spinocerebellar Ataxia
Intervention: Other: Motor training
6 Recruiting Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)
Condition: Choroidal Neovascularization
Intervention:
7 Recruiting A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Condition: Friedreich's Ataxia
Interventions: Procedure: Cardiac magnetic resonance imaging (CMR);   Procedure: Exercise-stress test;   Procedure: Echocardiography (ECHO);   Procedure: Cardiac-related blood studies
8 Not yet recruiting EDS in Ataxia Telangiectasia Patients
Conditions: Nervous System Disease;   Genetic Disease;   Rare Disease
Interventions: Drug: EDS-EP dose range of ~5-10 mg DSP/infusion;   Drug: EDS-EP dose range of ~14-22 mg DSP/infusion;   Drug: Placebo
9 Recruiting Natural History of Spinocerebellar Ataxia Type 7 (SCA7)
Condition: Spinocerebellar Ataxia
Intervention:
10 Not yet recruiting Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Condition: Ataxia-Telangiectasia
Interventions: Drug: Metformin;   Drug: Pioglitazone
11 Recruiting Rosuvastatin (Crestor) in Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Rosuvastatin
12 Recruiting Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
Condition: Late Onset Sporadic Cerebellar Ataxia
Intervention:
13 Recruiting (+) Epicatechin to Treat Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: (+)-Epicatechin
14 Recruiting A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants
Condition: Schizophrenia, Cerebellar Ataxia
Interventions: Drug: TAK-831;   Drug: TAK-831 Placebo
15 Recruiting Efficacy and Safety Study of Mesenchymal Stem Cells (Stemchymal®) in Polyglutamine Spinocerebellar Ataxia
Condition: Cerebellar Ataxia
Interventions: Biological: Stemchymal®;   Procedure: Excipients
16 Recruiting Biomarkers in Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention:
17 Recruiting Functional and Structural Imaging and Motor Control in Spinocerebellar Ataxia
Condition: Spinocerebellar Ataxia
Interventions: Behavioral: Error-reduction;   Behavioral: International Cooperative Ataxia Rating Scale;   Behavioral: Scale for the Assessment and Rating of Ataxia;   Behavioral: Beck Depression Inventory, 2nd Ed;   Behavioral: Stroop;   Behavioral: Purdue Pegboard;   Behavioral: Brief Test of Attention;   Behavioral: 6-minute Walk;   Behavioral: Hand Grip Dynamometer;   Behavioral: Montreal Cognitive Assessment;   Behavioral: Physical Performance Function;   Behavioral: Biomechanical Assessments of Dysmetria;   Behavioral: Neurophysiological assessment of brain activity;   Behavioral: Biomechanical gait analysis
18 Recruiting The EUROSCA Natural History Study
Condition: Spinocerebellar Ataxia
Intervention:
19 Recruiting Methylprednisolone Treatment of Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Methylprednisolone
20 Recruiting Evolution of Albumin on AOA1 Patients Supplemented With Coenzyme Q10
Condition: Ataxia-oculomotor Apraxia 1
Interventions: Dietary Supplement: CoQ10;   Other: Sanomit Placebo
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years